From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
- 18 June 2015
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 3 (3)
Abstract
Fungal infections constitute a major threat to an escalating number of critically ill patients. Fungi are eukaryotic organisms and, as such, there is a limited armamentarium of antifungal drugs, which leads to high mortality rates. Moreover, fungal infections are often associated with the formation of biofilms, which contribute to virulence and further complicate treatment due to the high level of antifungal drug resistance displayed by sessile cells within these microbial communities. Thus, the treatment of fungal infections associated with a biofilm etiology represents a formidable and unmet clinical challenge. The increasing importance and awareness of fungal biofilms is reflected by the fact that this is now an area of very active research. Studies in the last decade have provided important insights into fungal biofilm biology, physiology, and pathology, as well as into the molecular basis of biofilm resistance. Here we discuss how this accumulated knowledge may inform the development of new antibiofilm strategies and therapeutics that are urgently needed.Keywords
This publication has 107 references indexed in Scilit:
- Recent insights into Candida albicans biofilm resistance mechanismsCurrent Genetics, 2013
- A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicansCell, 2012
- The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicansAntimicrobial Agents and Chemotherapy, 2011
- Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilmsJournal of Antimicrobial Chemotherapy, 2011
- Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transitionOrganic & Biomolecular Chemistry, 2010
- Genetic Basis ofCandidaBiofilm Resistance Due to Drug‐Sequestering Matrix GlucanThe Journal of Infectious Diseases, 2010
- The use of chitosan to damage Cryptococcus neoformans biofilmsBiomaterials, 2010
- Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidineArchives of Oral Biology, 2009
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNature Protocols, 2008
- Role for Cell Density in Antifungal Drug Resistance in Candida albicans BiofilmsAntimicrobial Agents and Chemotherapy, 2007